Please use this identifier to cite or link to this item: https://doi.org/10.3389/fnins.2017.00073
DC FieldValue
dc.titleMembrane active antimicrobial peptides: Translating mechanistic insights to design
dc.contributor.authorLi, J
dc.contributor.authorKoh, J.-J
dc.contributor.authorLiu, S
dc.contributor.authorLakshminarayanan, R
dc.contributor.authorVerma, C.S
dc.contributor.authorBeuerman, R.W
dc.date.accessioned2020-11-17T06:35:36Z
dc.date.available2020-11-17T06:35:36Z
dc.date.issued2017
dc.identifier.citationLi, J, Koh, J.-J, Liu, S, Lakshminarayanan, R, Verma, C.S, Beuerman, R.W (2017). Membrane active antimicrobial peptides: Translating mechanistic insights to design. Frontiers in Neuroscience 11 (FEB) : 73. ScholarBank@NUS Repository. https://doi.org/10.3389/fnins.2017.00073
dc.identifier.issn1662-4548
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/183546
dc.description.abstractAntimicrobial peptides (AMPs) are promising next generation antibiotics that hold great potential for combating bacterial resistance. AMPs can be both bacteriostatic and bactericidal, induce rapid killing and display a lower propensity to develop resistance than do conventional antibiotics. Despite significant progress in the past 30 years, no peptide antibiotic has reached the clinic yet. Poor understanding of the action mechanisms and lack of rational design principles have been the two major obstacles that have slowed progress. Technological developments are now enabling multidisciplinary approaches including molecular dynamics simulations combined with biophysics and microbiology toward providing valuable insights into the interactions of AMPs with membranes at atomic level. This has led to increasingly robust models of the mechanisms of action of AMPs and has begun to contribute meaningfully toward the discovery of new AMPs. This review discusses the detailed action mechanisms that have been put forward, with detailed atomistic insights into how the AMPs interact with bacterial membranes. The review further discusses how this knowledge is exploited toward developing design principles for novel AMPs. Finally, the current status, associated challenges, and future directions for the development of AMP therapeutics are discussed. © 2017 Li, Koh, Liu, Lakshminarayanan, Verma and Beuerman.
dc.publisherFrontiers Media
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceUnpaywall 20201031
dc.subjectadenosine triphosphate
dc.subjectamino acid
dc.subjectbrilacidin
dc.subjectdimethyldioctadecylammonium bromide
dc.subjectexeporfinium chloride
dc.subjectpolymyxin B
dc.subjectpolypeptide antibiotic agent
dc.subjectporphyrin derivative
dc.subjecttranscription factor
dc.subjectunclassified drug
dc.subjectxf 73
dc.subjectantibiotic resistance
dc.subjectbacterial membrane
dc.subjectbactericidal activity
dc.subjectbacteriostasis
dc.subjectbiophysics
dc.subjectcell membrane
dc.subjectcross linking
dc.subjectdrug mechanism
dc.subjectepithelium cell
dc.subjectGram negative bacterium
dc.subjectGram positive bacterium
dc.subjecthydrophobicity
dc.subjectimmune response
dc.subjectinnate immunity
dc.subjectmethicillin resistant Staphylococcus aureus
dc.subjectmicrobiology
dc.subjectmolecular dynamics
dc.subjectnonhuman
dc.subjectpropensity score
dc.subjectReview
dc.subjectsimulation
dc.typeReview
dc.contributor.departmentBIOLOGY (NU)
dc.contributor.departmentDUKE-NUS MEDICAL SCHOOL
dc.description.doi10.3389/fnins.2017.00073
dc.description.sourcetitleFrontiers in Neuroscience
dc.description.volume11
dc.description.issueFEB
dc.description.page73
dc.published.statePublished
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3389_fnins_2017_00073.pdf1.93 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons